THE CRESCENT SURGERY — All Prescriptions & Medications — Page 2
Practice Code: P81092 | THORNTON-CLEVELEYS, FY5 3LF
Showing results 51-100 of 599
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Doxazosin mesilate | 1,369 | 49.3K | £1.5K | +28.2% ▲ |
| 1,348 | 2,801 | £92.0K | +147.3% ▲ | |
| Ibuprofen | 1,347 | 139.5K | £7.2K | +164.8% ▲ |
| Empagliflozin | 1,249 | 31.9K | £39.7K | +99.6% ▲ |
| Fexofenadine hydrochloride | 1,245 | 37.7K | £1.6K | +46.4% ▲ |
| Prednisolone | 1,199 | 51.8K | £2.0K | +50.1% ▲ |
| Naproxen | 1,152 | 40.7K | £1.6K | +16.7% ▲ |
| Rosuvastatin calcium | 1,132 | 30.2K | £820 | +26.1% ▲ |
| Carbocisteine | 1,131 | 129.6K | £5.1K | +111.8% ▲ |
| Mometasone furoate | 1,092 | 1,098 | £8.5K | +172.0% ▲ |
| Isosorbide mononitrate | 1,028 | 22.7K | £3.6K | +55.5% ▲ |
| Lamotrigine | 986 | 40.4K | £5.5K | +67.0% ▲ |
| Pravastatin sodium | 983 | 28.4K | £1.3K | +202.7% ▲ |
| Alginic acid compound preparations | 961 | 472.1K | £5.2K | +64.1% ▲ |
| Sildenafil (Erectile Dysfunction) | 925 | 5,028 | £932 | +83.5% ▲ |
| Venlafaxine | 923 | 34.2K | £5.9K | +9.3% ▲ |
| Thiamine hydrochloride | 916 | 44.5K | £1.2K | +73.8% ▲ |
| Ezetimibe | 844 | 21.8K | £3.8K | +18.6% ▲ |
| Spironolactone | 839 | 20.3K | £1.3K | +55.6% ▲ |
| Insulin degludec | 839 | 3,077 | £50.1K | +663.5% ▲ |
| Betahistine hydrochloride | 827 | 54.6K | £2.3K | +246.4% ▲ |
| 823 | 11.2K | £5.9K | +23.9% ▲ | |
| Senna | 806 | 45.0K | £999 | +33.9% ▲ |
| Amoxicillin | 806 | 31.0K | £966 | -13.5% ▼ |
| Ranolazine | 790 | 42.8K | £7.8K | +364.9% ▲ |
| Glucose blood testing reagents | 782 | 52.2K | £8.4K | -0.9% vs avg |
| Duloxetine hydrochloride | 733 | 23.5K | £2.0K | +15.3% ▲ |
| Risedronate sodium | 725 | 3,164 | £964 | +497.7% ▲ |
| Atenolol | 722 | 18.8K | £419 | +19.7% ▲ |
| Lactulose | 717 | 396.1K | £3.7K | +117.8% ▲ |
| Pramipexole | 717 | 28.2K | £3.3K | +630.3% ▲ |
| Montelukast | 715 | 19.8K | £966 | +4.4% ▲ |
| Esomeprazole | 703 | 26.8K | £2.6K | +73.7% ▲ |
| 695 | 7,986 | £3.0K | +178.5% ▲ | |
| Nefopam hydrochloride | 693 | 65.3K | £2.9K | +512.6% ▲ |
| Mebeverine hydrochloride | 691 | 52.4K | £2.2K | +122.5% ▲ |
| Cetirizine hydrochloride | 687 | 22.2K | £565 | +37.5% ▲ |
| Canagliflozin | 654 | 17.1K | £21.3K | +355.5% ▲ |
| Methotrexate | 654 | 9,620 | £21.9K | +100.9% ▲ |
| Famotidine | 643 | 16.3K | £10.2K | +31.8% ▲ |
| Insulin aspart | 628 | 2,959 | £18.5K | +64.9% ▲ |
| Mirabegron | 597 | 17.1K | £15.8K | +48.6% ▲ |
| Umeclidinium bromide/vilanterol | 592 | 601 | £18.6K | +203.6% ▲ |
| Quetiapine | 592 | 22.6K | £6.9K | -4.9% ▼ |
| 585 | 601 | £1.0K | +165.5% ▲ | |
| Doxycycline hyclate | 574 | 8,105 | £766 | +12.0% ▲ |
| Oxycodone hydrochloride | 570 | 47.3K | £5.8K | +122.7% ▲ |
| Flucloxacillin sodium | 564 | 25.1K | £1.5K | +25.4% ▲ |
| Quinine sulfate | 547 | 9,807 | £1.8K | +88.9% ▲ |
| Diazepam | 543 | 15.8K | £354 | +9.0% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.